UPC — Universe Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $87.73m
- $74.70m
- $32.31m
- 82
- 29
- 77
- 66
Annual cashflow statement for Universe Pharmaceuticals, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 7.55 | 7.56 | 11.3 | -8.74 | -6.16 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.113 | 0.023 | -0.229 | 0.436 | -0.488 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.16 | -1.87 | -12.9 | 7.06 | 6.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 13.2 | 6.12 | -2.06 | -1.31 | 1.12 |
| Capital Expenditures | -0.086 | -0.052 | -0.445 | -0.094 | -0.044 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | -26.6 | -3.81 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.086 | -0.052 | -27.1 | -3.91 | -0.044 |
| Financing Cash Flow Items | -16 | -0.441 | -2.79 | 0 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -16 | 0.47 | 26.6 | 3.32 | -1.39 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.01 | 6.88 | -1.98 | -2.37 | -0.426 |